Physical Function, Psychosocial Status, and Symptom Burden Among Adults with Plasma Cell Disorders and Associations with Quality of Life
Open Access
- 3 May 2022
- journal article
- research article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 27 (8) , 694-702
Abstract
The plasma cell disorders (PCDs), multiple myeloma (MM), and light-chain amyloidosis (AL) are disproportionately diseases of older adults, whose care may be complicated by frailty associated with advancing age. We sought to evaluate the prevalence of functional deficits and symptoms in a cohort of persons with PCDs and associations of demographic, disease-related, functional, and psychosocial measures with quality of life (QoL). Adults with PCDs were recruited into an observational registry in 2018-2020. Patients completed a functional assessment and European Organization for Research and Treatment of Cancer QoL questionnaire (QLQ-C30). Associations of covariates of interest with QoL were evaluated via univariate linear regression. Among 121 adults, the mean age was 68.6. Diagnoses were 74% MM, 14% AL, 7% both MM and AL, and 5% other PCDs. The median time from diagnosis was 34.9 months. Median lines of therapy were 2, with 11% having received ≥4th-line therapy. Patients with functional deficits had lower mean QoL scores: dependence in IADLs (66.3 vs. 79.9, P = .001) and recent falls (56.7 vs. 76.8, P = .001). Patients ≤6 months from diagnosis had lower QoL (66.7) than those ≥2 years from diagnosis (77.3, P = .03). However, patients on later lines of therapy (≥4th-line) had lower QoL (62.2) than those on 1st-line treatment (76.0, P = .04). Patients with physical impairments and more advanced PCDs had lower QoL than those without deficits or earlier in their disease course. Early identification of physical impairments may facilitate interventions that mitigate these deficits and thereby improve QoL for patients with PCDs.Keywords
Funding Information
- North Carolina University Cancer Research Fund
- University of North Carolina
- Geriatric Oncology Program (T32-CA233419)
- Cancer Control Education Program (T32-CA057726)
- Cancer Care Quality Training Program (T32-CA116339)
This publication has 39 references indexed in Scilit:
- Health‐related quality of life and disease‐specific complaints among multiple myeloma patients up to 10 yr after diagnosis: results from a population‐based study using the PROFILES registryEuropean Journal of Haematology, 2012
- Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain MeasurementsJournal of Clinical Oncology, 2012
- Implementing a Geriatric Assessment in Cooperative Group Clinical Cancer Trials: CALGB 360401Journal of Clinical Oncology, 2011
- Multiple MyelomaNew England Journal of Medicine, 2011
- Comprehensive Geriatric Assessment for Older Patients With CancerJournal of Clinical Oncology, 2007
- Developing a cancer‐specific geriatric assessmentCancer, 2005
- International Staging System for Multiple MyelomaJournal of Clinical Oncology, 2005
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993
- The Use of the Karnofsky Performance Scale in Determining Outcomes and Risk in Geriatric OutpatientsJournal of Gerontology, 1991
- The Development, Validity, and Reliability of the Oars Multidimensional Functional Assessment QuestionnaireJournal of Gerontology, 1981